Rate of CD4+ Cell Count Increase over Periods of Viral Load Suppression: Relationship with the Number of Previous Virological Failures

Clinical Infectious Diseases

Volumn 51, Issue 4, 2010, Pages 456-464

  Trotta, Maria Paola ^a   Cozzi Lepri, Alessandro ^j,k   Ammassari, Adriana ^a   Vecchiet, Jacopo ^e   Cassola, Giovanni ^f   Caramello, Pietro ^f   Vullo, Vincenzo ^b   Soscia, Fabrizio ^g   Chiodera, Alessandro ^f   Ladisa, Nicoletta ^h   Abeli, Clara ^f   Cauda, Roberto ^c   Buonuomi, Anna Rita ^d   Antinori, Andrea ^a   Monforte, Antonella D'arminio ⁱ  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e Infectious Diseases Clinic   (United States)

^f Galliera H ^*  (Italy)

^g AIDS Center   (Italy)

^h UNIVERSITY OF BARI   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF MINNESOTA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS LOAD; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; VIROLOGY;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE; VIRAL LOAD;

EID: 77955670919     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655151     Document Type: Article

References (21)

1. + count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008; 22: 841-848.
2. + count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-2296.
3. Lewden C, Chene G, Morlat P, et al. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007; 46:72-77.
4. + cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis 2007; 44:441-446.
5. Gras L, Kesselring AM, Griffin JT, et al. CD4 cell counts of 800 cells/ mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr 2007; 45:183-192.
6. Mocroft A, Phillips AN, Gatell J, et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370:407-413.
7. + cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 2009; 48:787-794.
8. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed 8 September 2009.
9. Battegay M, Nuesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 2006; 6:280-287.
10. Deeks SG, Wrin T, Liegler T, et al. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 2001; 344:472-480.
11. d'Arminio Monforte A, Lepri AC, Rezza G, et al; I.CO.N.A. Study Group. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. AIDS 2000; 14:499-507.
12. Kaufmann GR, Furrer H, Ledergerber B, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/ microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis 2005; 41:361-372.
13. Mocroft A, Phillips AN, Ledergerber B, et al. Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. AIDS 2006; 20:1141-1150.
14. Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003; 17:1907-1915.
15. + T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antivir Ther 2007; 12:889-897.
16. Kaufmann GR, Khanna N, Weber R, et al. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Antivir Ther 2004; 9:263-274.
17. Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 2003; 163:2187-2195.
18. Le Moing V, Thiébaut R, Chêne G, et al; ANRS CO8 (APROCO/ COPILOTE) Study Group. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently !500 copies/mL during treatment with antiretroviral drugs. HIV Med 2007; 8(3):156-163.
19. Murri R, Lepri AC, Cicconi P, et al. Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study. J Acquir Immune Defic Syndr 2006; 41:23-30.
20. + T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clin Infect Dis 2008; 47:1093-101.
21. Fox ZV, Geretti AM, Clotet B, et al. Association between resistance and CD4-count change in patients on ART with ongoing viremia. Antivir Ther 2007; 12:S102.